Multicenter evaluation of breast cancer patients’ satisfaction and experience with oncology telemedicine visits during the COVID-19 pandemicObservational Study Published on 2021-11-012022-10-05 Journal: British Journal of Cancer [Category] 유전자 메커니즘, 임상, [키워드] age Analysis anticancer Anxiety Breast cancer breast cancer patient cancers Clinical practice correlated COVID-19 COVID-19 pandemic disease status eligible evaluated First wave Follow-up France Italy limit oncology participant Patient receiving Satisfaction satisfaction score Telemedicine telemedicine visit therapy Treatment [DOI] 10.1038/s41416-021-01555-y PMC 바로가기 [Article Type] Observational Study
The Utilization and Benefits of Telehealth Services by Health Care Professionals Managing Breast Cancer Patients during the COVID-19 PandemicReview Published on 2021-10-192022-10-31 Journal: International journal for equity in health [Category] COVID-19, [키워드] Breast Breast cancer breast cancer patient Cancer Care caused conducted continuum coronavirus disease COVID-19 COVID-19 pandemic demonstrated Diagnosis Effectiveness examined feasibility geographical area Health increasingly individual literature review management managing outcomes pandemic Patient patients professional professionals Psychological Research Satisfaction service significantly telehealth Telemedicine teleoncology telerehabilitation Treatment utilization [DOI] 10.3390/healthcare9101401 PMC 바로가기 [Article Type] Review
PRO B: evaluating the effect of an alarm-based patient-reported outcome monitoring compared with usual care in metastatic breast cancer patients—study protocol for a randomised controlled trialPRO B: 전이성 유방암 환자에서 일반 치료와 비교하여 경보 기반 환자 보고 결과 모니터링의 효과 평가 - 무작위 대조 시험을 위한 연구 프로토콜Study Protocol Published on 2021-09-282022-09-10 Journal: Trials [Category] SARS, 임상, [키워드] 1:1 acute disease alarm among others approach ARMS Breast cancer breast cancer patient clinical Clinical practice Complete Contact control arm Controlled trial controls determined by develop disease domain elongation emergency room Endpoint enrolment ePROs fatigue female form Health apps hospitalisation hospitalisations identify include independent intervene Intervention intervention arm intervention group less life Metastatic breast cancer metastatic disease mobile devices outcome Patient Patient-reported outcomes Personalised medicine positive Primary outcome pros protocol Quality of life randomisation randomised randomised controlled trial receive recruited reported symptom reported symptoms required Research secondary Secondary endpoints selected Society supplementary material survival the patient transfer Treatment Trial Trigger usual care Value-based health care [DOI] 10.1186/s13063-021-05642-6 PMC 바로가기 [Article Type] Study Protocol
The impact of COVID-19 pandemic on the rate of newly diagnosed gynecological and breast cancers: a tertiary center perspectiveGynecologic Oncology Published on 2021-09-242022-10-27 Journal: Archives of gynecology and obstetrics [Category] COVID-19, [키워드] Breast cancer breast cancer patient Cancer cancers carcinoma clinical outcomes clinical parameter collected Comorbidity COVID-19 COVID-19 pandemic decrease diagnose diagnosed disease Gynecology lockdown lockdowns management measure Neoplasms pandemic Patient Patient care patients performance status Perspective reported Result risk significantly significantly more Symptom Symptoms Treatment tumor stage [DOI] 10.1007/s00404-021-06259-5 PMC 바로가기 [Article Type] Gynecologic Oncology
The impact of COVID-19 pandemic on the rate of newly diagnosed gynecological and breast cancers: a tertiary center perspectiveGynecologic Oncology Published on 2021-09-242022-10-27 Journal: Archives of gynecology and obstetrics [Category] Coronavirus, COVID-19, COVID19(2023년), Fulltext, SARS, [키워드] Breast cancer breast cancer patient Cancer cancers carcinoma clinical outcomes clinical parameter collected Comorbidity COVID-19 COVID-19 pandemic decrease diagnose diagnosed disease Gynecology lockdown lockdowns management measure Neoplasms pandemic Patient Patient care patients performance status Perspective reported Result risk significantly significantly more Symptom Symptoms Treatment tumor stage [DOI] 10.1007/s00404-021-06259-5 PMC 바로가기 [Article Type] Gynecologic Oncology
The potential role of abnormal angiotensin-converting enzyme 2 expression correlated with immune infiltration after SARS-CoV-2 infection in the prognosis of breast cancer비정상적인 안지오텐신-개수 효소 2 발현의 잠재적 역할은 유방암의 예후에서 SARS-COV-2 감염 후 면역 침윤과 상관 관계가 있었다.Research Paper Published on 2021-09-152022-09-10 Journal: Aging (Albany NY) [Category] MERS, SARS, 바이오마커, [키워드] ACE2 ACE2 expression analyzed angiotensin-converting enzyme 2 Breast cancer breast cancer patient breast cancer patients breast tumor CD4 CD8 CD8+ T cells CD8A CD8B CEACAM3 changes in contribute correlated correlation COVID-19 decrease Decreased Deterioration except for expression expression level immune infiltration luminal marker neutrophil Neutrophils positively correlated Prognosis S100A12 SARS-CoV-2 SARS-COV-2 infection significantly Subtypes T cell T cells tissue undergo [DOI] 10.18632/aging.203418 PMC 바로가기 [Article Type] Research Paper
Increased Use of Porch or Backyard Nature during COVID-19 Associated with Lower Stress and Better Symptom Experience among Breast Cancer PatientsArticle Published on 2021-08-282022-10-29 Journal: International Journal of Environmental Research an [Category] Coronavirus, MERS, SARS, [키워드] activity association average Backyard benefit Better Breast Breast cancer breast cancer patient Cancer Cancer patients cancer symptoms Care conducted Contact contact with COVID-19 COVID-19 pandemic cross-sectional survey decrease Decreased diagnosed distress evaluate expected experience female First wave flexible green space Health IMPROVE improvement Increased increasingly indoor nature Intervention Lower mental health Nature nature-watching pandemic parks participant passive nature Patients with cancer Perceived stress physical plants Porch promote public health reported significant increases in significantly significantly increased Stress Symptom symptom experience symptom severity while [DOI] 10.3390/ijerph18179102 PMC 바로가기 [Article Type] Article
The COVID-19 pandemic: An opportunity to rethink and harmonise the frequency of follow-up visits for patients with early stage breast cancerCOVID-19 범유행: 초기 유방암 환자의 후속 방문 빈도를 재고하고 조화시킬 수 있는 기회Article Published on 2021-06-012022-09-11 Journal: Cancer treatment reviews [Category] SARS, 임상, [키워드] adverse effect adverse effects assessment Bia Breast Breast cancer breast cancer patient changes in citation Clinical practice Cohort studies collaboration completion COVID-19 COVID-19 pandemic database disease disease free survival early stage eligible Endpoint evaluate Evidence examined finding Follow-up Follow-up interval. Follow-up visit Frequency had no IMPROVE independent initial initial treatment library life Patient prospective cohort study Quality Quality of life Randomized controlled trial Randomized controlled trials RCT RCTs reduced reduction in RoB scale searched statistically significant difference survival systematic review Treatment Trial was performed were assessed while [DOI] 10.1016/j.ctrv.2021.102188 PMC 바로가기 [Article Type] Article
Weathering the Storm: Managing Older Adults With Breast Cancer Amid COVID-19 and Beyond폭풍우 극복: COVID-19 및 그 이후의 유방암에 걸린 노인 관리Article Published on 2021-04-062022-09-11 Journal: Journal of the National Cancer Institute [Category] SARS, 바이오마커, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 aging patient approach Breast Breast cancer breast cancer patient breast cancer patients Care chemotherapy toxicity Comorbidity competing coronavirus COVID-19 COVID-19 pandemic Decision making diagnosed functional Functional status maintain managing metastatic disease myelosuppression Older older patient older patients promote respiratory risk SARS-CoV-2 severe acute respiratory syndrome Coronavirus the United State Therapeutic benefit Toxicity Treatment unique United States while [DOI] 10.1093/jnci/djaa079 PMC 바로가기 [Article Type] Article
COVID‐19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experienceShort Communication Published on 2021-03-062022-10-28 Journal: The Breast Journal [Category] COVID-19, MERS, [키워드] administration asymptomatic subjects breast cancer patient Cancer cancer centre cancer patient CDK4/6 inhibitors changes in COVID‐19 COVID‐19 Diagnosis disease dose reduction Elective surgery Endocrine Evidence HR positive/HER2 negative metastatic breast cancer increased risk Infection inherent inhibitor institution management neutropenia pandemic positive Radiotherapy receiving receptor recommendation reduction in reflect reported required risk suggested therapy Topic treated Treatment Tumor tumors [DOI] 10.1111/tbj.14204 PMC 바로가기 [Article Type] Short Communication